A Case of Coexistence of Bone Marrow-involved Refractory Marginal Zone B-Cell Lymphoma and Therapy-related Myelodysplastic Syndrome
Laboratory Medicine Online
;
: 98-101, 2016.
Artículo
en Inglés
| WPRIM
| ID: wpr-16398
ABSTRACT
Recent advances in chemotherapy have led to increased survival rates for patients with hematologic malignancies. However, standard chemotherapies, including alkylating agents for non-Hodgkin lymphoma, could induce therapy-related myeloid neoplasms (t-MNs), a group of disorders categorized by the World Health Organization in 2008. Here, we report a case of coexistence of bone marrow (BM)-involved refractory marginal zone B-cell lymphoma (MZL) and therapy-related myelodysplastic syndrome (t-MDS). Simultaneous presence of refractory lymphoma and t-MN in the BM is rare, and this is the first report in Korea. The patient received allogeneic hematopoietic stem cell transplantation (HSCT) to cure both the MZL and t-MDS. Since the HSCT, he has been stable for 21 months without any evidence of recurrence.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Recurrencia
/
Organización Mundial de la Salud
/
Médula Ósea
/
Síndromes Mielodisplásicos
/
Linfoma no Hodgkin
/
Tasa de Supervivencia
/
Linfoma de Células B de la Zona Marginal
/
Trasplante de Células Madre Hematopoyéticas
/
Neoplasias Hematológicas
/
Quimioterapia
Límite:
Humanos
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Laboratory Medicine Online
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS